Diagnostics: Page 55
-
UnitedHealthcare's depression test decision boosts Myriad's prospects
While Medicare only permits psychiatrists to order the test, the private payer will reimburse requests from all providers.
By Nick Paul Taylor • Aug. 2, 2019 -
DeepMind AI shows potential to accelerate kidney injury diagnosis
The Google sister company trained artificial intelligence to predict when patients are likely to develop acute kidney injury within the next 48 hours.
By Nick Paul Taylor • Aug. 1, 2019 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Appeals court kicks ACLA lawsuit back to lower court
The ruling is a blow to the government, which argued collection of market data was inextricably intertwined with the establishment of payment rates and therefore wasn't reviewable by the courts.
By David Lim • July 31, 2019 -
FDA clears Lyme disease tests, ending reliance on immunoblots
Zeus Scientific won the clearances after convincing the agency using enzyme immunoassays alone is as accurate as the current two-tiered approach.
By Nick Paul Taylor • July 30, 2019 -
Exact Sciences to gain breast, prostate cancer tests in $2.8B deal
The Cologuard maker is adding Genomic Health's Oncotype DX tests to its ranks, which together target a market worth an estimated $20 billion.
By Maria Rachal • July 29, 2019 -
Getty / Edited by BioPharma Dive
Consumer genetics dip drives LabCorp Q2 test volumes down
The 1.2% decline in organic diagnostic volume contrasts growth achieved by rival Quest. PAMA and managed care contracts also weighed on results.
By Nick Paul Taylor • July 25, 2019 -
PCORI, MD Anderson team up on lung cancer screening aid
Funded by the Patient-Centered Outcomes Research Institute, the project targets high-risk smokers for lung cancer screening. A second program looks to expand care for adolescents with behavior problems after traumatic brain injury.
By Susan Kelly • July 24, 2019 -
Quest reports volume growth despite loss of contracts
Executives at the lab testing giant disclosed it lost a few capitated contracts open for renewal during the second quarter due to a competitor offering lower rates than were profitable.
By David Lim • July 23, 2019 -
Medtronic to distribute AI stroke detection and triage software
The technology comes from Google Ventures-backed artificial intelligence startup Viz.ai, which won a De Novo clearance last year for its clinical decision support software aimed at speeding identification of large vessel occlusions.
By Maria Rachal • July 22, 2019 -
HER2 breast cancer imaging tech gets breakthrough nod
Imagion Biosystems is developing an alternative imaging system it hopes will speed cancer detection with the use of magnetic nanoparticles injected into the body to hunt for tumors.
By Susan Kelly • July 22, 2019 -
Random plasma glucose testing helps predict diabetes in large VA study
Department of Veterans Affairs researchers combing data from nearly 1 million patients found routine blood tests to be an overlooked but effective means of identifying patients at risk of developing the disease within five years.
By Susan Kelly • July 22, 2019 -
Abbott teases FreeStyle Libre potential beyond glucose monitoring
The company is expanding manufacturing of its blockbuster diabetes device, a technology CEO Miles White said could be expanded to track other analytes.
By Maria Rachal • July 17, 2019 -
Hospitals may boost outsourcing of lab services: UBS poll
LabCorp may benefit most from the increasing use of service providers, with nearly 10% more respondents expressing interest in working with the company over rival Quest Diagnostics.
By Nick Paul Taylor • July 17, 2019 -
Screenings fail to explain rise in colorectal cancer in younger adults, study finds
The American Cancer Society called for further study of the trend, saying factors beyond expanded use of colonoscopy testing may play a role in driving the increased incidence of colorectal cancer.
By Susan Kelly • July 15, 2019 -
WHO expands lists of essential in vitro diagnostics
New additions include 12 tests for detection of solid tumors like colorectal, liver, cervical, prostate, breast, germ cell and blood cancers, as well as lymphomas.
By Susan Kelly • July 10, 2019 -
Fitch Solutions tips Roche to challenge Philips for digital pathology market
After enjoying a brief monopoly, Philips faces a clutch of competitors planning regulatory filings.
By Nick Paul Taylor • July 10, 2019 -
Investment firm downgrades Myriad Genetics as growth thesis weakens
Cowen analysts made the decision in light of back-to-back quarters in which sales of key products fell short of expectations.
By Nick Paul Taylor • July 10, 2019 -
House lawmakers introduce bill to delay PAMA data collection
The clinical laboratory industry praised the legislation, which also calls on the National Academy of Medicine to make recommendations on how to improve the data collection process.
By Susan Kelly • July 1, 2019 -
Hologic promotes replacement to head diagnostics unit
Kevin Thornal, who is currently the president of the company's medical aesthetics division, will become the president of its diagnostics unit.
By Nick Paul Taylor • Updated July 22, 2019 -
OncoCyte delays liquid biopsy test for lung cancer again
The company expected to complete key studies around the middle of 2019 and bring the test to market by year's end, but has now abandoned the target.
By Nick Paul Taylor • June 27, 2019 -
MRI as safe as cardiac catheterization for coronary disease screening: NEJM
The study's author hopes less-invasive MRI scans will become more widely used for making treatment decisions for patients with stable chest pain, reducing the need for cardiac catheterization.
By Susan Kelly • June 25, 2019 -
Roche assay identifies Alzheimer's biomarker in blood samples
The assay predicted beta-amyloid status but fell short of being accurate enough to independently confirm the presence of the biomarker, according to research published in JAMA Neurology.
By Nick Paul Taylor • June 25, 2019 -
Cardiology practice pays $2.5M to settle case involving genetic testing kickback allegations
In the latest case involving improper billing of Medicare for genetic tests, Nevada Heart & Vascular Center allegedly referred patients to Natural Molecular Testing and Iverson Genetic Diagnostics for payments.
By Nick Paul Taylor • June 20, 2019 -
Mount Sinai joins LabCorp to adopt Philips' digital pathology
The clinical lab giant will integrate the system into Mount Sinai’s eight hospitals, enabling remote review of images and surgical slides.
By Nick Paul Taylor • June 19, 2019 -
Jacob Bell/MedTech Dive
Bio-Techne gains breakthrough status for liquid biopsy prostate test
The test analyzes a patient's exosomes to help doctors determine whether a prostate biopsy is needed in patients with an ambiguous PSA test result.
By Susan Kelly • June 18, 2019
Previous
